Arch Pharmachem Ltd - Charges

Every charge - open or closed - that lenders have registered against Arch Pharmachem Ltd, with the most recent activity at the top.

2000-12-05 Mumbai, Maharashtra Active Unlisted Active Compliant
Connect MCP
AP Arch Pharmachem Ltd
Open charges
3
3.90 cr
Closed charges
1
55.00 cr
Total
4
58.90 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Standard Chartered Investments And Loans… 1 55.00 cr
2 Sahakari Bank Ltd. 3 3.90 cr
All charges (4) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
10135594 Standard Chartered Investments And Loans India Limited 18 Nov 2008 - 18 Jun 2010 55.00 cr Closed
90144544 Sahakari Bank Ltd. 21 Jun 2003 - - 50.00 Lakh Open
90141082 Sahakari Bank Ltd. 02 Jan 2003 13 Mar 2003 - 85.00 Lakh Open
90144118 Sahakari Bank Ltd. 05 Oct 2002 - - 2.55 cr Open
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Arch Pharmachem Ltd?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Arch Pharmachem Ltd (CIN: U24231MH2000PLC129882). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Arch Pharmachem Ltd.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.